Related Experiment Video
Updated: Apr 14, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Eczema therapeutics in children: what do the clinical trials say?
1Department of Paediatrics, The Chinese University of Hong Kong, 6/F, Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong.
Insights
Eczema, or atopic dermatitis, is a chronic childhood condition with no cure. Management focuses on symptom variability, topical treatments, and avoiding triggers, with systemic options for severe cases.
Area of Science:
- Dermatology
- Allergology
- Immunology
Background:
- Eczema (atopic dermatitis) is a prevalent childhood atopic disease.
- It is characterized by chronicity and significantly impairs quality of life.
- Current treatments aim to manage symptoms as no cure exists.
Purpose of the Study:
- To review current therapeutic strategies for eczema (atopic dermatitis).
- To highlight the importance of individualized management approaches.
- To discuss various treatment modalities, including basic, anti-inflammatory, and systemic therapies.
Main Methods:
- Review of established and emerging treatments for atopic dermatitis.
- Discussion of basic management principles: education, hydration, trigger avoidance.
- Exploration of anti-inflammatory options: topical corticosteroids, calcineurin inhibitors.
- Consideration of systemic immunosuppressants for refractory cases.
- Inclusion of adjuvant therapies: UV irradiation, antimicrobial treatments.
- Evaluation of specific interventions: dietary changes, allergen immunotherapy.
- Mention of complementary and alternative medicine (CAM) in eczema management.
Main Results:
- Treatment relies on topical and systemic anti-allergic or immunomodulating therapies.
- Topical corticosteroids, macrolide immunosuppressants, and oral immunomodulating drugs are mainstays.
- Basic therapy includes patient education, topical hydration, and trigger avoidance.
- Anti-inflammatory treatments manage exacerbations and proactive therapy.
- Systemic immunosuppression is for severe, refractory cases.
- Microbial colonization may necessitate antimicrobial treatment.
- UV irradiation (UVA1, narrowband UVB) serves as adjuvant therapy.
- Dietary changes and allergen immunotherapy are indicated only when specific allergies are confirmed.
- CAM use is popular but lacks robust evidence.
Conclusions:
- Effective eczema management requires a personalized approach considering symptomatic variability.
- A combination of basic care, anti-inflammatory treatments, and potentially systemic therapies is crucial.
- Adjuvant therapies, specific dietary interventions, and immunotherapy have roles in select cases.
- While CAM is utilized, evidence-based data are limited, necessitating caution.
Abstract:
Eczema or atopic dermatitis is a common childhood atopic disease associated with chronicity and impaired quality of life. As there is no cure for the disease, treatment relies on topical and systemic anti-allergic or immunomodulating therapies. Topical corticosteroid, macrolide immunosuppressants, and oral immunomodulating drugs for recalcitrant disease have been the mainstay of therapy. Management of atopic dermatitis must consider the individual symptomatic variability of the disease. Basic therapy is focused on patient/family education, hydrating topical treatment, and avoidance of specific and non-specific provocative factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin inhibitors is used for exacerbation management and more recently in selective cases for proactive therapy. Systemic immunosuppressive treatment is an option for severe refractory cases. Microbial colonisation and superinfection may induce disease exacerbation and justify additional antimicrobial treatment. Adjuvant therapy includes ultraviolet (UV) irradiation preferably with UVA1 or narrowband UVB. Dietary recommendations should be specific and given only when food allergy is confirmed. Allergen-specific immunotherapy against aeroallergens may be useful in selected cases. Parallel use of traditional and proprietary topical and herbal medicine has also been popular in China and many cities in Asia. Complementary and alternative medicine may have a place but evidence-based data are lacking.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical Applications of Epidermal Stem Cells
Acne Infection
Preclinical Development: Overview

